Conning Inc. Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Conning Inc. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,629 shares of the medical equipment provider’s stock after purchasing an additional 249 shares during the quarter. Conning Inc.’s holdings in Intuitive Surgical were worth $1,894,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. CWM LLC raised its stake in Intuitive Surgical by 5.3% during the third quarter. CWM LLC now owns 43,152 shares of the medical equipment provider’s stock valued at $21,199,000 after buying an additional 2,162 shares during the last quarter. Quotient Wealth Partners LLC raised its position in shares of Intuitive Surgical by 5.7% in the 3rd quarter. Quotient Wealth Partners LLC now owns 1,522 shares of the medical equipment provider’s stock worth $748,000 after purchasing an additional 82 shares during the last quarter. Tobam boosted its stake in Intuitive Surgical by 13.9% in the 3rd quarter. Tobam now owns 662 shares of the medical equipment provider’s stock worth $325,000 after purchasing an additional 81 shares in the last quarter. Private Advisory Group LLC purchased a new stake in Intuitive Surgical during the 3rd quarter valued at about $398,000. Finally, Westwind Capital increased its stake in Intuitive Surgical by 67.8% during the 3rd quarter. Westwind Capital now owns 54,334 shares of the medical equipment provider’s stock valued at $26,693,000 after purchasing an additional 21,963 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,940 shares of company stock worth $3,333,485. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $582.98 on Friday. The stock has a 50-day simple moving average of $554.03 and a two-hundred day simple moving average of $513.12. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $207.65 billion, a PE ratio of 90.95, a P/E/G ratio of 5.51 and a beta of 1.39.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ISRG shares. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Finally, Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.